This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Diagnosis, Medication Selection, and Dosing for Specific Indications

Guideline 12: Selecting Treatments for Other Indications

 

Published: January 1, 2004

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

The experts did not recommend the use of an antipsychotic agent for any of the conditions listed below. If a patient with neuropathic pain has failed to respond to or tolerate a nonsteroidal anti-inflammatory agent and/or a cyclo-oxygenase-2 inhibitor, the experts considered an anticonvulsant the first-line treatment option, with a tricyclic antidepressant a high second-line alternative. For severe nausea and vomiting due to chemotherapy, a 5-HT3 antagonist (e.g., odansetron or granisetron) was rated high second line.’ ‹


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 65

Quick Links: Psychotic Disorders , Schizophrenia and Schizoaffective Disorders

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...